
Segtnan AI uses artificial intelligence to detect neurological disease early and to optimize virus testing workflows for healthcare providers. The company analyzes FDG-PET and other brain imaging using machine learning and 3D brain mapping to produce the Segtnan Brain Score, and it operates an AI- and cobot-powered testing platform that integrates with hospital and laboratory workflows. Its offerings are delivered as SaaS/subscription products via a serverless backend and mobile applications, targeting hospitals, clinical labs, and research institutions. Core technologies include AI/ML, FDG-PET image processing, 3D mapping, cobots for lab automation, and cloud/serverless infrastructure. The company is validated on thousands of patients across clinical sites and holds patents in Denmark with worldwide filings pending.

Segtnan AI uses artificial intelligence to detect neurological disease early and to optimize virus testing workflows for healthcare providers. The company analyzes FDG-PET and other brain imaging using machine learning and 3D brain mapping to produce the Segtnan Brain Score, and it operates an AI- and cobot-powered testing platform that integrates with hospital and laboratory workflows. Its offerings are delivered as SaaS/subscription products via a serverless backend and mobile applications, targeting hospitals, clinical labs, and research institutions. Core technologies include AI/ML, FDG-PET image processing, 3D mapping, cobots for lab automation, and cloud/serverless infrastructure. The company is validated on thousands of patients across clinical sites and holds patents in Denmark with worldwide filings pending.